Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Case report

Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report

Authors: Mudit Chowdhary, Umesh Narsinghani, Ritu A. Kumar

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Mycobacterium avium complex (MAC) is a ubiquitous pathogen, widely distributed in the environment including water, soil and animals. It is an uncommonly encountered clinical pathogen; primarily causing pulmonary infections in patients with underlying lung disease or disseminated disease in immunocompromised hosts. Sporadically, extra-pulmonary infections have been documented including involvement of the liver, spleen, skin, soft tissue and lymph nodes. Central nervous system (CNS) infections due to MAC are exceedingly rare and carry a poor prognosis. Additionally, such infections are largely reported in patients infected with HIV. Herein we report the first case of intracranial abscess due to MAC in an immunocompetent man with a normal CD4 count and negative HIV status.

Case presentation

A previously healthy 40-year-old male presented to us with progressively worsening CNS symptoms. The patient’s presentation was uncharacteristic of MAC infection in immunocompetent hosts, as he developed subacute, progressive symptoms that included severe frontal headaches, left eyelid swelling, blurry vision, and diplopia, without any pulmonary or systemic manifestations. Neuroimaging revealed multiple ring-enhancing lesions, which required neurosurgical intervention. MAC was the only pathogen that grew from intraoperative tissue cultures. The patient was subsequently treated with a 12-month regimen consisting of Clarithromycin, Ethambutol, and Rifampin, with successful clinical resolution.

Conclusion

Our findings indicate that it is important to consider rare infections such as MAC in immunocompetent patients, regardless of atypical symptoms. Despite the severity of this infection, with timely diagnosis effective treatment is available.
Literature
1.
go back to reference Martins AB, Matos ED, Lemos ACM. Infection With the Mycobacterium avium Complex in Patients Without Predisposing Conditions – A Case Report and Literature Review. Braz J Infect Dis. 2005;9(2):173–9.CrossRefPubMed Martins AB, Matos ED, Lemos ACM. Infection With the Mycobacterium avium Complex in Patients Without Predisposing Conditions – A Case Report and Literature Review. Braz J Infect Dis. 2005;9(2):173–9.CrossRefPubMed
2.
go back to reference Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis. 2008;8:390–98.CrossRefPubMed Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis. 2008;8:390–98.CrossRefPubMed
3.
go back to reference Lee M, Cheng A, Lee Y, Yang C, Lai C, Huang Y, et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother. 2012;67:222–5.CrossRefPubMed Lee M, Cheng A, Lee Y, Yang C, Lai C, Huang Y, et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother. 2012;67:222–5.CrossRefPubMed
4.
go back to reference Karne SS, Sangle SA, Kiyawat DS, Dharmashale SN, Kadam DB, Bhardwaj RS. Mycobacterium avium-intracellularle brain absecess in HIV-positive patient. Ann Indian Acad Neurol. 2012;15:54–5.CrossRefPubMedPubMedCentral Karne SS, Sangle SA, Kiyawat DS, Dharmashale SN, Kadam DB, Bhardwaj RS. Mycobacterium avium-intracellularle brain absecess in HIV-positive patient. Ann Indian Acad Neurol. 2012;15:54–5.CrossRefPubMedPubMedCentral
5.
go back to reference Negatu Y, Mekonen E. A Case Report of Mycobacterium Avium Complex Peritonitis in an AIDS patient. Case Reports in Infectious Diseases. 2013;2013:590478.CrossRefPubMedPubMedCentral Negatu Y, Mekonen E. A Case Report of Mycobacterium Avium Complex Peritonitis in an AIDS patient. Case Reports in Infectious Diseases. 2013;2013:590478.CrossRefPubMedPubMedCentral
6.
go back to reference Torriani FJ, McCutchan JA, Bozzette SA, Grafe MR, Havlir DY. Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia. J Infect Dis. 1994;170(6):1601–5.CrossRefPubMed Torriani FJ, McCutchan JA, Bozzette SA, Grafe MR, Havlir DY. Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia. J Infect Dis. 1994;170(6):1601–5.CrossRefPubMed
7.
go back to reference Jr HRJ. Mycobacterium avium Complex Infection in the Acquired Immunodeficiency Syndrome. N Engl J Med. 1991;324:1332–8.CrossRef Jr HRJ. Mycobacterium avium Complex Infection in the Acquired Immunodeficiency Syndrome. N Engl J Med. 1991;324:1332–8.CrossRef
8.
go back to reference Kim W, Jang S, Ok T, Kim GU PH, Leem J, Kang BH, et al. Disseminated Mycobacterium intracellulare Infection in an Immunocompetent Host. Tuberc Respir Dis. 2012;72:452–6.CrossRef Kim W, Jang S, Ok T, Kim GU PH, Leem J, Kang BH, et al. Disseminated Mycobacterium intracellulare Infection in an Immunocompetent Host. Tuberc Respir Dis. 2012;72:452–6.CrossRef
9.
go back to reference Arkun K, Gordon DA, Lincoln C, Levi M, Bello J, Keller CE, et al. Atypical mycobacterial brain abscess presenting as a spindle cell lesion in an immunocompetent patient. Clin Neuropathol. 2012;31(3):155–8.CrossRefPubMed Arkun K, Gordon DA, Lincoln C, Levi M, Bello J, Keller CE, et al. Atypical mycobacterial brain abscess presenting as a spindle cell lesion in an immunocompetent patient. Clin Neuropathol. 2012;31(3):155–8.CrossRefPubMed
10.
go back to reference O’Connell E, Rosen LB, Larue RW, Fabre V, Melia MT, Auwaerter PG, et al. Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-γ Autoantibodies. J Clin Immunol. 2014;34:928–32.CrossRefPubMed O’Connell E, Rosen LB, Larue RW, Fabre V, Melia MT, Auwaerter PG, et al. Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-γ Autoantibodies. J Clin Immunol. 2014;34:928–32.CrossRefPubMed
11.
go back to reference Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thoracic Soc. 2013;10(4):299–306.CrossRef Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thoracic Soc. 2013;10(4):299–306.CrossRef
12.
go back to reference Morrison A, Gyure KA, Stone J, Wong K, McEvoy P, Koeller K, et al. Mycobacterial spindle cell pseudotumor of the brain; a case report and review of the literature. Am J Surg Pathol. 1999;23:1294–9.CrossRefPubMed Morrison A, Gyure KA, Stone J, Wong K, McEvoy P, Koeller K, et al. Mycobacterial spindle cell pseudotumor of the brain; a case report and review of the literature. Am J Surg Pathol. 1999;23:1294–9.CrossRefPubMed
13.
go back to reference Uldry PA, Bogousslavsky J, Regli F, Chave JP, Beer V. Chronic Mycobacterium avium complex infection of the central nervous system in a non-immunosuppressed woman. Eur Neurol. 1992;32:285–8.CrossRefPubMed Uldry PA, Bogousslavsky J, Regli F, Chave JP, Beer V. Chronic Mycobacterium avium complex infection of the central nervous system in a non-immunosuppressed woman. Eur Neurol. 1992;32:285–8.CrossRefPubMed
14.
go back to reference Murray R, Mallal S, Heath C, French M. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis. 2011;20:199–201.CrossRef Murray R, Mallal S, Heath C, French M. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis. 2011;20:199–201.CrossRef
15.
go back to reference Berger P, Lepidi H, Drogoul-Vey MP, Poizot-Martin I, Drancourt M. Mycobacterium avium brain abscess at the initiation of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2004;23:142–4.CrossRefPubMed Berger P, Lepidi H, Drogoul-Vey MP, Poizot-Martin I, Drancourt M. Mycobacterium avium brain abscess at the initiation of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2004;23:142–4.CrossRefPubMed
16.
go back to reference Verma R, Dhamija R. Disseminated Mycobacterium avium-intracellulare infection presenting as multiple ring-enhancing lesions on brain MRI. Mayo Clin Proc. 2009;84:394.CrossRefPubMedPubMedCentral Verma R, Dhamija R. Disseminated Mycobacterium avium-intracellulare infection presenting as multiple ring-enhancing lesions on brain MRI. Mayo Clin Proc. 2009;84:394.CrossRefPubMedPubMedCentral
17.
go back to reference Fortin C, Rouleau D. Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy. Can J Infect Dis Med Microbiol. 2005;16:187–9.PubMedPubMedCentral Fortin C, Rouleau D. Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy. Can J Infect Dis Med Microbiol. 2005;16:187–9.PubMedPubMedCentral
18.
go back to reference Calfee DP, Wespelwey B. Brain abscess, subdural empyema, and intracranial epidural abscess. Curr Infect Dis Rep. 1999;1:166–71.CrossRefPubMed Calfee DP, Wespelwey B. Brain abscess, subdural empyema, and intracranial epidural abscess. Curr Infect Dis Rep. 1999;1:166–71.CrossRefPubMed
19.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. This official statement of the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) was adopted by the ATS Board of Directors, September 2006, and by the IDSA Board of Directors, January 2007. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. This official statement of the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) was adopted by the ATS Board of Directors, September 2006, and by the IDSA Board of Directors, January 2007. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRefPubMed
20.
go back to reference Nau R, Sorgel F, Eiffert H. Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections. Clin Microbiol Rev. 2010;23(4):858–83.CrossRefPubMedPubMedCentral Nau R, Sorgel F, Eiffert H. Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections. Clin Microbiol Rev. 2010;23(4):858–83.CrossRefPubMedPubMedCentral
21.
go back to reference Mindermann T, Zimmerli W, Gratzl O. Rifampin Concentrations in Various Compartments of the Human Brain: A Novel Method for Determining Drug Levels in the Cerebral Extracellular Space. Antimicrob Agents Chemoter. 1998;42(10):2626–9. Mindermann T, Zimmerli W, Gratzl O. Rifampin Concentrations in Various Compartments of the Human Brain: A Novel Method for Determining Drug Levels in the Cerebral Extracellular Space. Antimicrob Agents Chemoter. 1998;42(10):2626–9.
Metadata
Title
Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report
Authors
Mudit Chowdhary
Umesh Narsinghani
Ritu A. Kumar
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-1026-5

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.